Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis

This publication has 21 references indexed in Scilit:

• Effect of mutations in the PCSK9 gene on the cell surface LDL receptors
  Human Molecular Genetics, 2006
• Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart Disease
  New England Journal of Medicine, 2006
• A Spectrum of PCSK9 Alleles Contributes to Plasma Levels of Low-Density Lipoprotein Cholesterol
  American Journal of Human Genetics, 2006
• The IDEAL Cholesterol
  JAMA, 2005
• Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein With Intensive Statin Therapy
  Journal of the American College of Cardiology, 2005
• Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemia
  Clinical Genetics, 2004
• A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree
  Human Genetics, 2004
• Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
  Nature Genetics, 2003
• A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood
  Proceedings of the National Academy of Sciences, 1999
• A Receptor-Mediated Pathway for Cholesterol Homeostasis
  Science, 1986